Lexaria Bioscience Corp. (LEXX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Sales/Revenue | 20K | 0 | 174K | 174K | 174K | 183.92K | 84K | 84K | 145K | 151.28K | -3.43K | 77.71K | 20.02K | 97.73K | 111.15K | 99.72K | 30.65K | 13.88K | 31.02K | 204.06K |
| Revenue Growth % | -88.51% | -100% | 107.14% | 107.14% | 20% | 21.58% | 2546.84% | 8.1% | 624.09% | 54.78% | -103.09% | -22.07% | -34.67% | 604.14% | 258.31% | -51.13% | -84.04% | -95.31% | -76.8% | 460.24% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 2.72K | 0 | 0 | 0 | 4.82K | 0 | 12.75K | 2.96K | 15.79K | 41.25K | 18.64K | 6.39K | 5.57K | 20.31K | 59.99K |
| COGS % of Revenue | - | - | - | - | - | 1.48% | - | - | - | 3.19% | - | 16.4% | 14.77% | 16.16% | 37.11% | 18.69% | 20.84% | 40.13% | 65.47% | 29.4% |
| Gross Profit | 20K | 0 | 174K | 174K | 174K | 181.2K | 84K | 84K | 145K | 146.46K | -3.43K | 64.96K | 17.07K | 81.94K | 69.9K | 81.08K | 24.26K | 8.31K | 10.71K | 144.07K |
| Gross Margin % | 100% | - | 100% | 100% | 100% | 98.52% | 100% | 100% | 100% | 96.81% | 100% | 83.6% | 85.23% | 83.84% | 62.89% | 81.31% | 79.16% | 59.87% | 34.53% | 70.6% |
| Gross Profit Growth % | -88.51% | -100% | 107.14% | 107.14% | 20% | 23.73% | 2546.84% | 29.31% | 749.59% | 78.74% | -104.91% | -19.88% | -29.66% | 886.04% | 552.55% | -43.72% | -84.97% | -96.41% | -91.12% | 794.6% |
| Operating Expenses | 1.47M | 1.57M | 2.86M | 3.92M | 2.93M | 2.87M | 2.29M | 1.83M | 813K | 1.29M | 1.07M | 2.47M | 1.34M | 1.78M | 1.58M | 2.5M | 1.47M | 2.01M | 1.44M | 2.71M |
| OpEx % of Revenue | 7359.52% | - | 1645.17% | 2255.41% | 1681.04% | 1561.47% | 2722.7% | 2174.9% | 560.69% | 849.82% | -31082.99% | 3173.23% | 6695.09% | 1818.55% | 1424.26% | 2506.51% | 4805.66% | 14494.18% | 4640.95% | 1328.38% |
| Selling, General & Admin | 996.51K | 902.29K | 980.48K | 1.21M | 1.24M | 918.69K | 1.32M | 1.25M | 567.23K | 711.11K | 566.67K | 825.18K | 644.51K | 947.87K | 1.23M | 1.75M | 1.2M | 1.55M | 1.08M | 2.26M |
| SG&A % of Revenue | 4982.57% | - | 563.49% | 693.63% | 712.12% | 499.5% | 1571.26% | 1492.65% | 391.19% | 470.07% | -16506.64% | 1061.91% | 3218.55% | 969.84% | 1103.8% | 1752.28% | 3906.2% | 11189.36% | 3493.32% | 1105.67% |
| Research & Development | 475.39K | 671.34K | 1.88M | 2.72M | 1.69M | 1.95M | 967.21K | 573.09K | 245.78K | 574.49K | 500.41K | 1.64M | 696.18K | 829.49K | 356.19K | 752.1K | 275.69K | 458.71K | 439.79K | 454.44K |
| R&D % of Revenue | 2376.94% | - | 1081.68% | 1561.78% | 968.92% | 1061.98% | 1151.44% | 682.25% | 169.5% | 379.76% | -14576.35% | 2111.33% | 3476.54% | 848.71% | 320.46% | 754.23% | 899.46% | 3304.82% | 1417.73% | 222.71% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -83.79K | 0 |
| Operating Income | -1.45M | -1.57M | -2.69M | -3.75M | -2.75M | -2.69M | -2.2M | -1.74M | -668K | -1.14M | -1.07M | -2.4M | -1.32M | -1.7M | -1.51M | -2.42M | -1.45M | -2M | -1.43M | -2.57M |
| Operating Margin % | -7259.52% | - | -1545.17% | -2155.41% | -1581.04% | -1462.95% | -2622.7% | -2074.9% | -460.69% | -753.01% | 31182.99% | -3089.64% | -6609.86% | -1734.71% | -1361.37% | -2425.2% | -4726.5% | -14434.31% | -4606.42% | -1257.77% |
| Operating Income Growth % | 47.22% | 41.52% | -22.04% | -115.18% | -311.83% | -136.2% | -105.8% | 27.4% | 49.53% | 32.81% | 29.25% | 0.72% | 8.63% | 15.38% | -5.89% | 5.77% | -31.16% | -180.95% | -84.92% | -86.19% |
| EBITDA | -1.43M | -1.56M | -2.67M | -3.72M | -2.75M | -2.66M | -2.21M | -1.73M | -652.07K | -1.11M | -999.58K | -2.38M | -1.3M | -1.67M | -1.45M | -2.39M | -1.42M | -1.98M | -1.37M | -2.54M |
| EBITDA Margin % | -7164.01% | - | -1532.87% | -2137.62% | -1579.73% | -1444.9% | -2631.93% | -2056.96% | -449.71% | -733.99% | 29116.92% | -3057.45% | -6486.37% | -1709.41% | -1304.39% | -2401.24% | -4641.14% | -14233.08% | -4400.72% | -1244.09% |
| EBITDA Growth % | 47.87% | 41.42% | -20.64% | -115.27% | -321.54% | -139.34% | -121.17% | 27.27% | 49.8% | 33.54% | 31.06% | 0.78% | 8.69% | 15.43% | -6.2% | 5.68% | -32.13% | -188.32% | -83.52% | -87.99% |
| D&A (Non-Cash Add-back) | 19.1K | 16.87K | 21.4K | 30.95K | 2.28K | 33.2K | -7.76K | 15.07K | 15.93K | 28.78K | 70.93K | 25.01K | 24.73K | 24.73K | 63.33K | 23.89K | 26.16K | 27.93K | 63.81K | 27.93K |
| EBIT | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.3M | -2.57M |
| Net Interest Income | 1.77K | 12 | 2.82K | 190 | 0 | 11 | 6.99K | 0 | 0 | 7.32K | 9.02K | 15.44K | 14.99K | 3.74K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 1.77K | 12 | 2.82K | 190 | 0 | 11 | 6.99K | 0 | 0 | 7.32K | 9.02K | 15.44K | 14.99K | 3.74K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.77K | -22.08K | -8.63K | -40.19K | 34.04K | -15.92K | 16.49K | -41.39K | 15.27K | -45.9K | -178.5K | 17.3K | 12.99K | -73.89K | 0 | 0 | 0 | 0 | 126.29K | 0 |
| Pretax Income | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.3M | -2.57M |
| Pretax Margin % | -7250.67% | - | -1550.13% | -2178.51% | -1561.48% | -1471.61% | -2603.06% | -2124.18% | -450.16% | -783.35% | 36382.61% | -3067.38% | -6545.01% | -1810.31% | -1361.37% | -2425.2% | -4726.5% | -14434.31% | -4199.3% | -1257.77% |
| Income Tax | 2.6K | 1.79K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.18% | -0.11% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.45M | -1.6M | -2.7M | -3.79M | -2.71M | -2.7M | -2.18M | -1.78M | -649.54K | -1.18M | -1.24M | -2.37M | -1.3M | -1.76M | -1.47M | -2.38M | -1.43M | -1.99M | -1.18M | -2.56M |
| Net Margin % | -7249.89% | - | -1549.33% | -2177.64% | -1559.32% | -1470.02% | -2600.94% | -2121.06% | -447.96% | -779.57% | 36100.17% | -3051.86% | -6482.55% | -1796.64% | -1320.26% | -2389.69% | -4651.8% | -14359.92% | -3797.72% | -1253.09% |
| Net Income Growth % | 46.56% | 41.01% | -23.39% | -112.67% | -317.71% | -129.26% | -76.29% | 24.87% | 49.96% | 32.84% | 15.55% | 0.48% | 8.95% | 11.9% | -24.56% | 6.81% | -452.82% | -186.36% | -64.78% | -87.82% |
| Net Income (Continuing) | -1.45M | -1.6M | -2.7M | -3.79M | -2.72M | -2.71M | -2.19M | -1.78M | -652.73K | -1.19M | -1.25M | -2.38M | -1.31M | -1.77M | -1.51M | -2.42M | -1.45M | -2M | -1.3M | -2.57M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -392.19K | -389.44K | -386.94K | -385.55K | -384.04K | -380.28K | -377.35K | -375.57K | -372.95K | -369.75K | -364.04K | -354.34K | -342.28K | -329.78K | -316.41K | -270.72K | -235.31K | -212.41K | -202.09K | -77.51K |
| EPS (Diluted) | -0.06 | -0.07 | -0.14 | -0.21 | -0.15 | -0.16 | -0.17 | -0.13 | -0.06 | -0.13 | -0.12 | -0.37 | -0.22 | -0.30 | -0.25 | -0.40 | -0.24 | -0.35 | -0.23 | -0.50 |
| EPS Growth % | 60% | 53.37% | 17.65% | -61.54% | -148.76% | -23.08% | -41.67% | 64.86% | 72.59% | 56.67% | 52% | 7.5% | 8.33% | 14.29% | -8.7% | 20% | -366.67% | -52.17% | 11.54% | -2.04% |
| EPS (Basic) | -0.06 | -0.07 | -0.14 | -0.21 | -0.15 | -0.16 | -0.17 | -0.13 | -0.06 | -0.13 | -0.12 | -0.37 | -0.22 | -0.30 | -0.25 | -0.40 | -0.24 | -0.35 | -0.23 | -0.50 |
| Diluted Shares Outstanding | 24.44M | 21.38M | 19.56M | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M |
| Basic Shares Outstanding | 24.44M | 21.38M | 19.56M | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |